KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Operating Margin: 2020-2025

Historic Operating Margin for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -231.78%.

  • Ginkgo Bioworks Holdings' Operating Margin fell 16979.00% to -231.78% in Q3 2025 from the same period last year, while for Sep 2025 it was -192.76%, marking a year-over-year increase of 9826.00%. This contributed to the annual value of -246.54% for FY2024, which is 9722.00% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Operating Margin stood at -231.78%, which was down 75.42% from -132.13% recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Operating Margin ranged from a high of -34.37% in Q3 2021 and a low of -1,134.55% during Q4 2021.
  • Its 3-year average for Operating Margin is -294.29%, with a median of -236.29% in 2024.
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Operating Margin tumbled by 96,021bps in 2021 and then spiked by 89,966bps in 2022.
  • Quarterly analysis of 5 years shows Ginkgo Bioworks Holdings' Operating Margin stood at -1,134.55% in 2021, then spiked by 89,966bps to -234.89% in 2022, then crashed by 27,760bps to -512.49% in 2023, then soared by 27,620bps to -236.29% in 2024, then plummeted by 16,979bps to -231.78% in 2025.
  • Its Operating Margin was -231.78% in Q3 2025, compared to -132.13% in Q2 2025 and -184.13% in Q1 2025.